JPMorgan Faces Legal Challenges Over Alleged Overpayments for Prescription Drugs

In a significant legal development, JPMorgan Chase & Co. is facing a lawsuit from a former employee who claims the bank excessively overpaid for its prescription drug benefits. The accusations arise from the assertion that JPMorgan mismanaged its health plan, resulting in inflated costs for prescription medications.

Continue reading

Florida Takes Steps to Demand Prescription Data from Pharmacy Benefit Managers

In a significant move to bolster transparency and accountability within the healthcare system, Florida has announced plans to require Pharmacy Benefit Managers (PBMs)—the intermediaries that negotiate drug prices on behalf of insurance companies—to disclose detailed prescription data. This announcement comes amid increasing scrutiny over the role of PBMs in driving up costs for consumers and insurance plans.

Continue reading

New York State Unveils Strict Regulations for Pharmacy Benefit Managers

In a significant move aimed at curbing the influence of Pharmacy Benefit Managers (PBMs), New York State has introduced new regulations that are expected to reshape how these organizations operate. The legislation primarily targets well-known names in the industry such as CVS, Cigna, and UnitedHealth, enforcing greater transparency and accountability in their practices.

Continue reading